AA
BEAM icon

Ancora Advisors’s Beam Therapeutics BEAM Stock Holding History

Ancora Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19K Hold
50
– – ﹤0.01% 2215
2025
Q4 		$1.39K Hold
50
– – ﹤0.01% 2199
2025
Q3 		$1.21K Hold
50
– – ﹤0.01% 1749
2025
Q2 		$850 Hold
50
– – ﹤0.01% 1769
2025
Q1 		$976 Hold
50
– – ﹤0.01% 1594
2024
Q4 		$1.24K Hold
50
– – ﹤0.01% 1613
2024
Q3 		$1.23K Hold
50
– – ﹤0.01% 1589
2024
Q2 		$1.17K Hold
50
– – ﹤0.01% 1639
2024
Q1 		$1.65K Hold
50
– – ﹤0.01% 1575
2023
Q4 		$1.36K Hold
50
– – ﹤0.01% 1518
2023
Q3 		$1.2K Hold
50
– – ﹤0.01% 1548
2023
Q2 		$1.6K Hold
50
– – ﹤0.01% 1511
2023
Q1 		$1.53K Hold
50
– – ﹤0.01% 1565
2022
Q4 		$2K Hold
50
– – ﹤0.01% 1575
2022
Q3 		$2K Hold
50
– – ﹤0.01% 1772
2022
Q2 		$2K Hold
50
– – ﹤0.01% 1928
2022
Q1 		$3K Buy
+50
New +$3.28K ﹤0.01% 2061

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Ancora Advisors's BEAM Position: Q1 2026 in Review

Ancora Advisors held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 50 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2215.

Ancora Advisors first reported a position in BEAM in Q1 2022 and has held it in 17 quarters since. The position peaked at $3K in Q1 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Ancora Advisors held 50 shares of Beam Therapeutics worth $1.19K as of Q1 2026.
  • Ancora Advisors left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #2215 holding.
  • Ancora Advisors first reported a position in Beam Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Ancora Advisors's Beam Therapeutics position peaked at $3K in Q1 2022.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.